Skip to main content

Table 4 Bone metastases free survival after LT

From: Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation

  

Bone metasta ses-free survival

Pvalue

  

≤ 1 year

> 1 year

χ2 test Logistic

Gender

Female

2 (6.7%)

2 (6.7%)

1.00

 

Male

16 (53.3%)

10 (33.3%)

 

Age

≤50

11 (36.7%)

6 (20.0%)

0.711

 

>50

7 (23.3%)

6 (20.0%)

 

HbsAg

-

3 (10.0%)

0 (0%)

0.255

 

+

15 (50.0%)

12 (40.0%)

 

Γ-GT

≤75

8 (26.7%)

6 (20.0%)

1.00

 

>75

10 (33.3%)

6 (20.0%)

 

AFP

≤400

9 (30.0%)

7 (23.3%)

0.722

 

>400

9 (30.0%)

5 (16.7%)

 

Child-Pugh Classification

A

14 (46.7%)

8 (26.7%)

0.678

 

B

4 (13.3%)

4 (13.3%)

 

Shanghai criteria

Exceeding

11 (36.7%)

3 (10.0%)

0.072 0.053

 

Within

7 (23.3%)

9 (30.0%)

 

UCSF

Exceeding

13 (43.3%)

5 (16.7%)

0.136

 

Within

5 (16.7%)

7 (23.3%)

 

Milan

Exceeding

13 (43.3%)

7 (23.3%)

0.694

 

Within

5 (16.7%)

5 (16.7%)

 

Interval between diagnosis of HCC and LT

≤0.5 year

8 (26.7%)

9 (30.0%)

0.141

 

>0.5 year

10 (33.3%)

3 (10.0%)

 

Soft-tissue extension

Absent

16 (53.3%)

5 (16.7%)

0.013 0.052

 

Present

2 (6.7%)

7 (23.3%)

 

No. of bone metastases

Solitary

6 (20.0%)

8 (26.7%)

0.135

 

≥2 sites

12 (40.0%)

4 (13.3%)

 

Intrahepatic tumor control

uncontrolled

9 (30.0%)

1 (3.3%)

0.045 0.018

 

Well-controlled

9 (30.0%)

11 (36.7%)

 

Concurrent distant metastases

Absent

10 (33.3%)

5 (16.7%)

0.710

 

Present

8 (26.7%)

7 (23.3%)

Â